Forum Discussion
CDK Inhibitors approved by PBAC 20 April 2018
CDK Inhibitors approved by the Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue. See the link below for further information https://www.bcna.org.au/news/2018/04/cdk-i...
I am on the compassionate access program for Ribociclib and it is at no cost to me until they decide on a price for the PBS, then , as I am on a disability pension I will pay $6.40 per script.